Secondary Prevention With the Lifestyle Tool
Secondary Prevention of Cardiovascular Disease With the Lifestyle Tool
1 other identifier
interventional
11,000
1 country
1
Brief Summary
In this study participants will be randomized to use a digital lifestyle tool over three years or to a control group without access to the tool. The investigators will prospectively follow the incidence of major cardiovascular events in patients who have previously suffered from a myocardial infarction in those using the tool regularly and those in the control group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cardiovascular-diseases
Started Apr 2022
Longer than P75 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2022
CompletedFirst Posted
Study publicly available on registry
April 4, 2022
CompletedStudy Start
First participant enrolled
April 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
July 16, 2025
July 1, 2025
4.7 years
March 25, 2022
July 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of major adverse cardiovascular event
Incidence of major adverse cardiovascular event, defined as cardiovascular death, myocardial infarction, stroke, or hospitalization for heart failure compared between participants regularly using the tool and on usual care.
3 years
Study Arms (2)
Usage of tool
EXPERIMENTALParticipants get access to the tool and use it regularly
Controls on usual care
NO INTERVENTIONParticipants who get randomized to control cannot access the tool. Development of cardiovascular disease is followed via clinical registries.
Interventions
Eligibility Criteria
You may qualify if:
- age 35 to 80 years
- myocardial infarction within one year prior to enrolment
- access to computer or mobile phone.
You may not qualify if:
- conditions or treatments that in the judgement of the Investigator could affect the study evaluation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Skane University Hospital
Malmo, 20502, Sweden
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Anders Rosengren, Professor
Göteborg University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2022
First Posted
April 4, 2022
Study Start
April 6, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2028
Last Updated
July 16, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Data will be available after publication.
- Access Criteria
- To researchers who provide a methodologically sound proposal in order to achieve the aims of that proposal. Proposals should be directed by email to internetverktyg@gu.se
Individual participant data that underlie the results will be shared after deidentification.